Lixiana 30 mg tablets are prescribed to prevent blood clots in conditions like non-valvular atrial fibrillation, reducing the risk of stroke. They are also effective in treating deep vein thrombosis (DVT) and pulmonary embolism (PE). The active ingredient, edoxaban, works by inhibiting Factor Xa, a key component in the blood clotting process. This specific 30 mg dosage is recommended for patients with moderate to severe kidney impairment, low body weight (≤60 kg), or those taking certain medications that interact with edoxaban. Regular use as directed by a healthcare professional helps manage and prevent thromboembolic events. . Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
